Please assess the completion status of the following clinical trial:

Trial Title: A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female subjects 21-90 years of age~* subjects has urinary incontinence on 3 day bladder diary~* subject has severe incontinence~* urine dipstick or urine culture negative for urinary tract infection~* cystometrogram without stress urinary leakage~* must have failed at least one anti-cholinergic medication~* negative urine pregnancy test on day of administration of study medication~Exclusion Criteria:~* history of carcinoma of the bladder~* presence of foreign body in the bladder, cystitis or other correctable etiology for Urge Urinary Incontinance~* gross fecal incontinence~* known allergy to sulfa or ciprofloxacin or to lidocaine~* any medical condition that may put the subject at increased risk with exposure to Botox~* females who are pregnant, breast-feeding, or planning a pregnancy during the study or who are of child-bearing potential~* known allergy to any of the components in the study medication~* prior documented resistance to Botox~* evidence of recent alcohol or drug abuse~* concurrent participation in another investigational drug or device study within 30 days

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): Placebo
- 2 (Type: EXPERIMENTAL): Botox

Based on this trial design, predict the completion outcome and termination type (if applicable).